Back to top

Achieve Life Sciences resumed with a Strong Buy at Raymond James

Raymond James resumed coverage of Achieve Life Sciences (ACHV) with a Strong Buy rating and $20 price target Achieve’s cytisinicline, supported by ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Achieve Life Sciences, Inc. (ACHV)